# Camarena Health

Health Center, CA
Page: https://astrelis.co/providers/health_center/051824  
This twin: https://astrelis.co/providers/health_center/051824.md  
CMS Certification Number (CCN): 051824  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 71,225. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -25.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 29. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 9.9%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $77.2M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +14.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Camarena Health, CA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000416570
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000368777
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000042402

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 31,666,216 [derived, p.6] | 17,823,330 [derived, p.6] | 9,876,155 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 7,929,697 [derived, p.6] | 6,076,866 [derived, p.6] | 5,930,074 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 3,829,374 [derived, p.6] | 3,414,298 [derived, p.6] | 3,362,910 [derived, p.6] |
| other current assets (Statement of financial position) | 774,528 [derived, p.6] | 793,226 [derived, p.6] | 734,626 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 44,199,815 [extracted, p.6] | 28,107,720 [extracted, p.6] | 19,903,765 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 83,184,996 [derived, p.6] | 76,068,089 [derived, p.6] | 66,970,876 [derived, p.6] |
| other long-term assets (Statement of financial position) | 35,068,878 [derived, p.6] | 26,741,583 [derived, p.6] | 5,442,163 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 162,453,689 [extracted, p.6] | 130,917,392 [extracted, p.6] | 92,316,804 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 7,440,112 [derived, p.6] | 7,109,647 [derived, p.6] | 6,931,944 [derived, p.6] |
| deferred revenue (Statement of financial position) | 1,500 [derived, p.6] | 1,500 [derived, p.6] | 18,485 [derived, p.6] |
| current debt and leases (Statement of financial position) | 2,071,734 [derived, p.6] | 2,662,955 [derived, p.6] | 1,934,420 [derived, p.6] |
| other current liabilities (Statement of financial position) | 5,970,449 [derived, p.6] | 3,696,371 [derived, p.6] | 3,688,314 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 15,483,795 [extracted, p.6] | 13,470,473 [extracted, p.6] | 12,573,163 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 80,599,725 [derived, p.6] | 65,090,609 [derived, p.6] | 26,775,348 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 96,083,520 [extracted, p.6] | 78,561,082 [extracted, p.6] | 39,348,511 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 65,919,133 [derived, p.6] | 51,532,607 [derived, p.6] | 52,472,801 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 451,036 [derived, p.6] | 823,703 [derived, p.6] | 495,492 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 66,370,169 [extracted, p.6] | 52,356,310 [extracted, p.6] | 52,968,293 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 76,224,125 [derived, p.7] | 63,968,046 [derived, p.7] | 55,813,650 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 5,762,200 [derived, p.7] | 3,234,981 [derived, p.7] | 2,651,498 [derived, p.7] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 7,041,844 [derived, p.7] | 7,243,803 [derived, p.7] | 7,808,554 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 20,442,114 [derived, p.7] | 9,274,381 [derived, p.7] | 6,545,334 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 109,470,283 [extracted, p.7] | 83,721,211 [extracted, p.7] | 72,819,036 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 57,599,042 [derived, p.7] | 51,838,060 [derived, p.7] | 41,850,544 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 5,293,233 [derived, p.7] | 5,130,668 [derived, p.7] | 4,550,810 [derived, p.7] |
| purchased and professional services (Statement of activities) | 15,794,820 [derived, p.7] | 12,933,565 [derived, p.7] | 10,901,377 [derived, p.7] |
| occupancy (Statement of activities) | 3,976,391 [derived, p.7] | 3,699,616 [derived, p.7] | 3,334,263 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 4,792,661 [derived, p.7] | 4,542,177 [derived, p.7] | 3,779,648 [derived, p.7] |
| interest (Statement of activities) | 2,320,541 [derived, p.7] | 1,939,486 [derived, p.7] | 914,918 [derived, p.7] |
| other expenses (Statement of activities) | 5,307,069 [derived, p.7] | 4,577,833 [derived, p.7] | 3,875,345 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 95,083,757 [extracted, p.7] | 84,661,405 [extracted, p.7] | 69,206,905 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | 14,386,526 [extracted, p.7] | -940,194 [extracted, p.7] | 3,612,131 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | -372,667 [derived, p.7] | 328,211 [derived, p.7] | 130,873 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | 14,013,859 [extracted, p.7] | -611,983 [extracted, p.7] | 3,743,004 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 52,356,310 [extracted, p.7] | 52,968,293 [extracted, p.7] | 49,225,289 [extracted, p.7] |
| net assets, end (Statement of activities) | 66,370,169 [extracted, p.7] | 52,356,310 [extracted, p.7] | 52,968,293 [extracted, p.7] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 128 days [plausible] | 81 days [plausible] | 55 days [plausible] |
| Current ratio | 2.85x [plausible] | 2.09x [plausible] | 1.58x [plausible] |
| Operating margin | 13.1% [plausible] | -1.1% [plausible] | 5.0% [plausible] |
| Total margin | 12.8% [plausible] | -0.7% [plausible] | 5.1% [plausible] |
| Patient revenue share | 69.6% [plausible] | 76.4% [plausible] | 76.6% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 60.6% [plausible] | 61.2% [plausible] | 60.5% [plausible] |
| Days in patient receivables | 38 days [plausible] | 35 days [plausible] | 39 days [plausible] |
| Debt to net assets | 1.25x [plausible] | 1.29x [plausible] | 0.54x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Camarena Health; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Camarena Health", https://astrelis.co/providers/health_center/051824, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.